EUR J PHARM SCI 润色咨询

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

出版年份：1993 年文章数：3946 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：7.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2021-05-08 whynot6688

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：中药单体;肝癌
    经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2017-11-01 12084be0m20(暂无昵称)

    请问该杂志的版面费贵吗？谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2017-10-17 ms1660087976288132

    发了一篇，一个special issue的邀稿。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2016-09-13 大卫的

    刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2016-09-01 ms6336778790072332

    审稿和出版速度挺快，效率高。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2016-03-28 xuanza

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2016-03-10 dividniu

    药品检验可以在这个期刊投稿吗

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2016-03-10 dividniu

    药品检验可以在这个期刊投稿吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2012-03-30 匿名用户

    审稿较慢，under review 状态已有45天。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=963774, encodeId=d276963e74d6, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：中药单体;肝癌<br>经验分享：效率还是不错的，一周后审，两周审完，然后等待编辑做决定一周。有两个审稿人不同意，要求比较苛刻，三分的杂志5+的要求。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Sat May 08 18:13:57 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548800, encodeId=55075488009c, content=请问该杂志的版面费贵吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac142186483, createdName=12084be0m20(暂无昵称), createdTime=Wed Nov 01 09:24:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=838771, encodeId=7daa838e712d, content=发了一篇，一个special issue的邀稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ecf5414129, createdName=ms1660087976288132, createdTime=Tue Oct 17 21:41:48 CST 2017, time=2017-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527105, encodeId=79a252e105fd, content=刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=406, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3daf1662481, createdName=大卫的, createdTime=Tue Sep 13 10:39:00 CST 2016, time=2016-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833608, encodeId=41938336089b, content=审稿和出版速度挺快，效率高。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Thu Sep 01 11:14:03 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520822, encodeId=6cb6520822d8, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还可以，一审周期5周，审稿人比较负责，提出的意见比较中肯，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211029/b028317b63d34410a473f4d7529ff638/ecf72ac0456243629c07ca4fcf36bf86.jpg, createdBy=e8bc1604674, createdName=xuanza, createdTime=Mon Mar 28 23:07:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520066, encodeId=3c6e52006625, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520064, encodeId=15ac52006432, content=药品检验可以在这个期刊投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a2e1698699, createdName=dividniu, createdTime=Thu Mar 10 20:45:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487654, encodeId=b24f48e654b8, content=审稿较慢，under review 状态已有45天。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Mar 30 22:04:00 CST 2012, time=2012-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817670, encodeId=323881e670bf, content=从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f70b5414147, createdName=ms1913270821714094, createdTime=Mon Jan 09 14:18:00 CST 2012, time=2012-01-09, status=1, ipAttribution=)]
    2012-01-09 ms1913270821714094

    从投稿到接收一共5个月左右，周期还是有点长，中间返修一次。总的来说该杂志并不要求工作量要有多大，但idea一定要比较新，建议工作较新工作量不大的可以投这个杂志。审稿人很负责，提的意见也很专业。因为之前投过ijp，所以比较起来就是工作不是很新但工作量较大可以投ijp，工作量不太大但工作较新可以投ejps。

    0

共32条页码: 2/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分